Jayson Parker is Faculty Lead for Digital Health Technologies for the Master of Biotechnology Program. He is also an Associate Professor, Teaching Stream in the Department of Biology at the University of Toronto Mississauga and is cross-appointed to the Institute of Biomaterials & Biomedical Engineering (BME) at the University of Toronto. In addition, he has lectured in the Faculty of Law. He was a medical advisor to the hedge fund Burlington Capital.
Previously, he was a medical liaison operating in medical affairs for the pharmaceutical companies Novo Nordisk and Schering AG.
He has worked in the investment banking industry as a buy side biotechnology stock analyst for Investor’s Group and Bolton Trembley. He was the Director of Equity Research (Medical) for AIC Limited (now Portland).
As a research associate, he has worked for the Addiction Research Foundation (now CAMH) on animal models of alcohol abuse. In addition, he joined the medical imaging department at Sunnybrook Hospital and conducted research on Alzheimer patients through 3 dimensional reconstructions of patient brains from MRI scans.
He obtained his Ph.D. in Physiology (neuroscience focus) based on his research on brain trauma at the University of Toronto and his MBA from Wilfried Laurier University. His Master’s degree from the University of Toronto focused on the neurobiology of cocaine addiction.
Lastly, he is an active Dungeons & Dragons player
BTC1800H › Biotechnology in Medicine
BTC1882H › Digital Ethnography in Health
BTC1899H › Digital Health Technology
Ph.D. (Physiology, University of Toronto)
M.B.A. (Wilfred Laurier)